文化大學機構典藏 CCUR:Item 987654321/36128
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 47249/51115 (92%)
Visitors : 14027000      Online Users : 269
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/36128


    Title: Novel therapeutic effects of sesamin on diabetes-induced cardiac dysfunction
    Authors: Thuy, TD (Tran Duong Thuy)
    Phan, NN (Nam Nhut Phan)
    Wang, CY (Wang, Chih-Yang)
    Yu, HG (Yu, Han-Gang)
    Wang, SY (Wang, Shu-Yin)
    Huang, PL (Huang, Pung-Ling)
    Do, YY (Do, Yi-Yin)
    Lin, YC (Lin, Yen-Chang)
    Contributors: 生科所
    Keywords: Sesamin
    cardiac dysfunction
    diabetes
    Date: 2017-05
    Issue Date: 2017-06-08 09:49:42 (UTC+8)
    Abstract: Diabetes is a risk factor that increases the occurrence and severity of cardiovascular events. Cardiovascular complications are the leading cause of mortality of 75% of patients with diabetes >40 years old. Sesamin, the bioactive compound extracted from Sesamum indicum, is a natural compound that has diverse beneficial effects on hypoglycemia and reducing cholesterol. The aim of this study is to investigate sesamin effects to diabetes-inducing cardiac hypertrophy. In the present study bioinformatics analysis demonstrated cardiac hypertrophy signaling may be the most important pathway for upregulating genes in sesamin-treated groups. To verify the bioinformatics prediction, sesamin was used as the main bioactive compound to attenuate the impact of diabetes induced by streptozotocin (STZ) on cardiac function in a rat model. The results revealed that oral administration of sesamin for 4 weeks (100 and 200 mg/kg body weight) marginally improved blood glucose levels, body weight and significantly ameliorated the effects on heart rate and blood pressure in rats with type 1 diabetes relative to control rats. The QT interval of sesamin was also reduced relative to the control group. The findings indicated that sesamin has potential cardioprotective effects in the STZ-induced diabetes model. This suggested that this can be used as a novel treatment for patients with diabetes with cardiac dysfunction complication.
    Relation: MOLECULAR MEDICINE REPORTS 卷: 15 期: 5頁碼: 2949-2956
    Appears in Collections:[Graduate Institute of Biotechnology ] journal articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML333View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©  2006-2025  - Feedback